Search results for "Streamline"
Article
Lessons Learned Accelerate Vaccine Development
He also notes that efforts are underway to streamline the timing of proof-of-concept clinical studies for new vaccines so that they can be more rapidly evaluated for efficacy prior to large-scale deve…
Article
Framing Biopharma Success in 2016
Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016.
By Rita C. Peters
The US biopharmaceutical industry turned a new page in 2015 when…
Article
Biopharma Advances Demand Specialized Expertise
Jun 15, 2015
By BioPharm International Editors
BioPharm International eBooks
Volume 28, Issue 13
Contract service providers share insights on biopharma market developments and the impl…
Article
Continuous Manufacturing: A Changing Processing Paradigm
Other advantages of continuous manufacturing include consistent product quality; smaller equipment; streamlined processes; low process cycle times; reduced operating costs; increased flexibility; elim…
Article
SEC in the Modern Downstream Purification Process
The low technical threshold and ease of process development will streamline the manufacturing process so that the barriers to getting a product to market are reduced. Vaccine products generally requir…
Article
The Bullish Outlook for Biosimilars
Feb 01, 2015
By Jill E. Sackman, PhD, Michael J. Kuchenreuther, PhD
BioPharm International
There are several important reasons for stakeholders to be optimistic about prospects for b…
Article
What Drove Biopharma Development in 2014?
And while QbD may be a federal requirement, the technique has emerged as a tangible tool to speed time to market, reduce recalls and rejects, minimize post-approval changes, streamline data flows acro…
Article
New Era for Generic Drugs
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
Nov 1, 2014
By: Jill Wechsler
BioPharm International
Volume 11, Issue …
Article
Viral Clearance Challenges in Bioprocessing
Comprehensive risk analysis is often effective for highlighting and prioritizing such evaluations to streamline costly virus testing, according to Greenhalgh.
Process representation
Another chal…
Article
FDA Seeks Metrics to Define Drug Quality
An upgraded IT platform could compile information from all sources on sites and products to support a streamlined, risk-based inspection process. This initiative also could evaluate FDA performance, s…